GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Issuance of Debt

AP Biosciences (ROCO:6945) Issuance of Debt : NT$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Issuance of Debt?

AP Biosciences's Issuance of Debt for the six months ended in Jun. 2024 was NT$0.00 Mil.

AP Biosciences's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00 Mil.


AP Biosciences Issuance of Debt Historical Data

The historical data trend for AP Biosciences's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Issuance of Debt Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Issuance of Debt
- - - -

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Issuance of Debt Get a 7-Day Free Trial - - - - -

AP Biosciences Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AP Biosciences Issuance of Debt Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


AP Biosciences Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines